SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-18-001029
Filing Date
2018-10-17
Accepted
2018-10-17 12:08:46
Documents
1
Group Members
KNIGHT THERAPEUTICS INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G jaguar_13g.htm SC 13G 69241
  Complete submission text file 0001019056-18-001029.txt   70914
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88872 | Film No.: 181125814
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8
Business Address 3400 BOULEVARD DE MAISONNEUVE WEST SUITE 1055 MONTREAL A8 H3Z 3B8 5144844483
Knight Therapeutics Inc (Filed by) CIK: 0001756235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G